Contract 75N95023P00436
Sino Biological Us Inc. · Department Of Health And Human Services · July 17, 2023
Sino Biological Us Inc. was awarded a federal contract by Department Of Health And Human Services (National Institutes Of Health) on July 17, 2023 for $55,000 of work in biological product (except diagnostic) manufacturing. Performance is in Chesterbrook, PA. It was awarded under full and open competition. The contract has been modified 1 time since the base award It uses firm fixed-price contract pricing. The most recent modification was on October 25, 2023.
Contract details
- PIID
- 75N95023P00436
- Award type
- Purchase Order
- Pricing
- Firm Fixed Price
- Set-aside
- No Set Aside Used.
- Competition
- Not Competed Under Sap
- NAICS
- 325414 · Biological Product (Except Diagnostic) Manufacturing
- Product / service
- Drugs And Biologicals
- Place of performance
- Chesterbrook, PA
- First action
- July 17, 2023
- Latest action
- October 25, 2023
Description
ANTIVIRAL DRUG DEVELOPMENT OF HYBRIDOMA CELL LINES AND ANTIBODY FOR VIRAL ANTIGENS
Modification timeline
-
October 25, 2023Mod P00001$-10.8K
-
July 17, 2023Base award$65.5K
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Bio-Rad Laboratories, Inc. | Department Of Health And Human Services | March 31, 2026 | $20.6K |
| Georgia Tech Research Corp | Department Of Health And Human Services | March 28, 2026 | $145.8K |
| Seqirus Inc | Department Of Health And Human Services | March 25, 2026 | $23.7K |
| Seqirus Inc | Department Of Health And Human Services | March 24, 2026 | $0 |
| Battelle Memorial Institute | Department Of Health And Human Services | March 19, 2026 | $2.80M |
| Sanofi Vaccines Us Inc. | Department Of Health And Human Services | March 19, 2026 | $53.21M |
Top contractors in NAICS 325414
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Pfizer Inc | 3 | $15.27B |
| 2 | Sanofi Vaccines Us Inc. | 606 | $9.38B |
| 3 | Regeneron Pharmaceuticals Inc | 1 | $5.57B |
| 4 | Merck Sharp & Dohme Corp. | 56 | $3.99B |
| 5 | Emergent Biodefense Operations Lansing Llc | 16 | $3.34B |
| 6 | Merck Sharp & Dohme Llc | 15 | $3.33B |
| 7 | Pfizer Inc. | 25 | $3.11B |
| 8 | Glaxosmithkline Holdings (Americas) Inc. | 109 | $2.24B |
| 9 | Modernatx, Inc. | 1 | $1.75B |
| 10 | Bavarian Nordic A/S | 1 | $1.01B |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 75N95023P00436?
Contract 75N95023P00436 is a federal contract awarded to Sino Biological Us Inc. by Department Of Health And Human Services on July 17, 2023 for $55,000 of work classified under BIOLOGICAL PRODUCT (EXCEPT DIAGNOSTIC) MANUFACTURING. It has been modified 1 time since the base award.
Who won contract 75N95023P00436?
Sino Biological Us Inc. won contract 75N95023P00436 from Department Of Health And Human Services.
How much is contract 75N95023P00436 worth?
Contract 75N95023P00436 has obligated $55,000 to date.